ChinaBio Today -- Cellonis Biotechnologies of Beijing announced it used a novel technology based on stem cells to eliminate a glioma – brain cancer – in a 36-year-old Norwegian patient. According to the company, the treatment shows an activated immune system can kill tumor stem cells and cancer daughter cells. Cellonis administered the stem-cell-based therapy along with conventional cancer treatments and TCM drugs. More details...
